Some people infected with Covid-19 during the pandemic's early months experienced peripheral neuropathy, pain, tingling and numbness in the hands and feet, during and following their bouts with the virus, finds a new study.
The study, published in the journal Pain, found that those who tested positive for the virus were about three times more likely to report pain, numbness or tingling in their hands and feet as those with negative tests.
"Several viral infections, such as HIV and shingles, are associated with peripheral neuropathy because viruses can damage nerves," said co-author Simon Haroutounian from the Washington University.
"We found that nearly 30 per cent of patients who tested positive for Covid-19 also reported neuropathy problems at the time of their diagnosis and that for 6 per cent to 7 per cent of them, the symptoms persisted for at least two weeks, and up to three months, suggesting this virus may have lingering effects on peripheral nerves," Haroutounian added.
For the study, the team surveyed patients who were tested for Covid-19 from March 16, 2020, through January 12, 2021. Of the 1,556 study participants, 542 had positive Covid-19 tests, and 1,014 tested negative.
Many of those who tested negative were tested because they were undergoing surgery or were already hospitalised with cancer, diabetes or other health problems, Haroutounian said.
Because of those existing health problems, many who tested negative already experienced chronic pain and neuropathy unrelated to Covid-19, he added.
Study patients who tested positive tended to be healthier and younger, and 29 per cent reported symptoms of neuropathy at the time of their diagnosis.
That compared to neuropathy problems in about 13 per cent of the participants who tended to have health challenges but tested negative for Covid-19.
--IANS
vc/ksk/
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)